UPDATE 3-FDA approves Global Blood Therapeutics sickle cell disease drug

The U.S. Food and Drug Administration said on Monday it approved a drug from Global Blood Therapeutics Inc to treat sickle cell disease in adults and children 12 years or older.

from Reuters: Company News https://ift.tt/2KV8mHo